Inactive Instrument
Cyprotex plc Stock London S.E.
Stocks
GB00BP25RZ14
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| Manager | Title | Age | Since |
|---|---|---|---|
Stephen Madden
COO | Chief Operating Officer | 60 | 28/03/2023 |
| Corporate Secretary | - | 26/09/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Stephen Madden
BRD | Director/Board Member | 60 | 28/03/2023 |
Dirk Ullmann
BRD | Director/Board Member | 60 | 01/01/2025 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.48% | +7.20% | -5.08% | +2.45% | 46.2B | |
| +2.19% | +11.71% | +385.81% | +632.13% | 38.71B | |
| +2.53% | +13.93% | +20.85% | -10.61% | 31.9B | |
| +1.65% | +3.61% | +9.98% | +55.42% | 31.12B | |
| -4.16% | -2.58% | +8.74% | +15.22% | 23.77B | |
| -0.32% | +12.96% | - | - | 16.2B | |
| +1.37% | +14.53% | +71.80% | +134.14% | 15.05B | |
| +1.00% | +10.30% | +13.31% | +22.84% | 13.74B | |
| +3.63% | +9.53% | +104.07% | +107.62% | 13.42B | |
| Average | +0.82% | +9.14% | +76.18% | +119.90% | 25.57B | |
| Weighted average by Cap. | +0.75% | +8.71% | +86.69% | +140.75% |
- Stock Market
- Stocks
- Stock
- Stock
Select your edition
All financial news and data tailored to specific country editions
